Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Houot

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Advances in Hematology|April 12, 2014
Results of a Prospective Study of High-Dose or Conventional Anthracycline-Cyclophosphamide Regimen Plus Radiotherapy for Localized Adult Non-Hodgkin's Primary Bone LymphomaA Schmidt-Tanguy, R Houot, S Lissandre, et al.
Leukemia|November 28, 2013
Cyclophosphamide as a first-line therapy in LGL leukemiaA Moignet, Z Hasanali, R Zambello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2010
18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS groupX Cahu, C Bodet-Milin, E Brissot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2016
Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSAR Houot, C Soussain, H Tilly, et al.
Revue Neurologique|December 20, 2024
Primary central nervous system lymphoma of the spinal cord: A LOC network cohort studyN Valyraki, G Ahle, E Tabouret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2026
Cytokine Release Symptoms rather than Syndromes: A call for Granular Reporting of Cytokine Related Adverse Events in Clinical TrialsJ-D Fumet, M Roulleaux Dugage, F-X Danlos, et al.
Annals of Hematology|March 29, 2023
Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network studyJ Dufour, S Choquet, K Hoang-Xuan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2013
Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSAA Trebouet, T Marchand, R Lemal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 21, 2011
Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMSR Houot, S Le Gouill, M Ojeda Uribe, et al.
Bone Marrow Transplantation|April 25, 2017
High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective studyE Schorb, C P Fox, K Fritsch, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Advances in Hematology|April 12, 2014
Results of a Prospective Study of High-Dose or Conventional Anthracycline-Cyclophosphamide Regimen Plus Radiotherapy for Localized Adult Non-Hodgkin's Primary Bone LymphomaA Schmidt-Tanguy, R Houot, S Lissandre, et al.
Leukemia|November 28, 2013
Cyclophosphamide as a first-line therapy in LGL leukemiaA Moignet, Z Hasanali, R Zambello, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 27, 2010
18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS groupX Cahu, C Bodet-Milin, E Brissot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2016
Inhibition of Hedgehog signaling for the treatment of lymphoma and CLL: a phase II study from the LYSAR Houot, C Soussain, H Tilly, et al.
Revue Neurologique|December 20, 2024
Primary central nervous system lymphoma of the spinal cord: A LOC network cohort studyN Valyraki, G Ahle, E Tabouret, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2026
Cytokine Release Symptoms rather than Syndromes: A call for Granular Reporting of Cytokine Related Adverse Events in Clinical TrialsJ-D Fumet, M Roulleaux Dugage, F-X Danlos, et al.
Annals of Hematology|March 29, 2023
Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network studyJ Dufour, S Choquet, K Hoang-Xuan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2013
Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSAA Trebouet, T Marchand, R Lemal, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 21, 2011
Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMSR Houot, S Le Gouill, M Ojeda Uribe, et al.
Bone Marrow Transplantation|April 25, 2017
High-dose thiotepa-based chemotherapy with autologous stem cell support in elderly patients with primary central nervous system lymphoma: a European retrospective studyE Schorb, C P Fox, K Fritsch, et al.
Pageof 3